PharmedOut
@Pharmed_Out
Followers
2K
Following
422
Media
154
Statuses
4K
PharmedOut is a project at Georgetown that advances evidence-based prescribing and educates about pharmaceutical and medical device marketing practices.
Georgetown University Med Ctr
Joined May 2011
Air Embolism Deaths Tied to Watchman LAA Closure Device Access Systems
medpagetoday.com
FDA warns of 120 serious injuries and 17 deaths associated with the issue
0
0
0
Hormones don't prevent disease in menopausal women! New Pharmanipulation podcast with Dr. Garnet Anderson of the Women's Health Initiative and health activist Cindy Pearson tells the truth about #menopause and menopausal hormone therapy.
open.spotify.com
Pharmanipulation · Episode
0
0
0
Morton Mintz was a great muckraking Washington Post reporter who exposed the Dalkon Shield and profiled Frances Kelsey’s work on thalidomide that was crucial in passing the 1962 Kefauver-Harris Amendment, a law that required drug efficacy before approval.
washingtonpost.com
A pioneer in consumer affairs journalism, he helped expose the deformity-causing hazards posed by thalidomide, a once-popular drug for morning sickness.
0
1
3
Many drug companies are selling drugs directly to consumers.
fiercepharma.com
With high drug prices remaining an ongoing concern for U.S. | A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.
1
0
1
Fugh-Berman tells MedPage Today that Makary-convened 'Expert Panel’ on menopause was “a parody” #MisinformedMakary
medpagetoday.com
Do panels cherry-pick experts and evidence that align with FDA leadership's views?
0
0
3
Wrong again, Dr. Makary. Menopausal hormone therapy helps symptoms, but harms outweigh benefits for chronic disease. #MisinformedMakary.
aafp.org
Recent publications in the medical literature and the popular press misattribute dozens of symptoms to menopause, stressing the health benefits of menopausal hormone therapy while underplaying its...
No clinical trial has ever shown that hormone replacement therapy for perimenopausal women increases the likelihood of dying of breast cancer. While some women can’t take HRT, the vast majority of women going through perimenopause can have both short and long-term health
1
1
3
Sarepta Refuses F.D.A. Request to Pull Duchenne Drug Linked to 3 Patient Deaths via @NYTimes.
nytimes.com
The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Elevidys, after three patients died from liver failure after taking it or a similar treatment.
0
0
0
This is misinformation. Estrogen+progestin increased mortality through 11 years, but not at 20 years. Breast cancer incidence increased by 24% at 5.6 years and remained elevated at 20 year follow-up. Estrogen alone was associated with decreased risk.
pubmed.ncbi.nlm.nih.gov
For postmenopausal women, the WHI randomized clinical trials do not support menopausal hormone therapy to prevent cardiovascular disease or other chronic diseases. Menopausal hormone therapy is...
The 2002 Women’s Health Initiative study caused millions of women to avoid hormone replacement therapy for fear of breast cancer. Amazingly – despite the headlines – the study DID NOT show any statistically significant increase in breast cancer mortality due to HRT.
1
2
2
Dr.Makary: You are wrong. Randomized controlled trials show that menopausal hormone therapy does not prevent heart attacks or cardiovascular disease. #MisinformedMakary.
pubmed.ncbi.nlm.nih.gov
For postmenopausal women, the WHI randomized clinical trials do not support menopausal hormone therapy to prevent cardiovascular disease or other chronic diseases. Menopausal hormone therapy is...
Studies have shown that when a woman starts estrogen (or estrogen + progesterone) within 10 years of the onset of menopause, there is a ~25-50% reduction in fatal heart attacks and cardiovascular disease. That's enormously significant, given that heart disease is the leading
0
1
4
Dick Durbin (D-IL) spearheaded a Direct-To-Consumer Telehealth Platform exposé of Big Pharma-telehealth partnerships that essentially sell drugs directly to consumers. Read “Big Pharma’s New Sales Scheme: Expanding Patient Access or a Virtual Pill Mill?"
1
3
1
Makary's menopause panel was rife with misinformation. Read about the real benefits and harms of menopausal hormone therapies here:
aafp.org
Recent publications in the medical literature and the popular press misattribute dozens of symptoms to menopause, stressing the health benefits of menopausal hormone therapy while underplaying its...
0
0
1
Cindy Pearson, women's health activist, disrupts "unbalanced and one-sided" panel on menopause treatments convened by FDA head; Pearson asked Makary to hold public meeting.
nytimes.com
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated.
1
0
1
Fugh-Berman and Mintzes editorial in American Family Physician cited in NY Times:.F.D.A. Panel to Reassess Hormone Therapy Warnings via @NYTimes.
nytimes.com
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated.
0
0
0
Dr. Fugh-Berman and Dr. Barbara Mintzes published an editorial today in American Family Physician that summarizes the evidence on menopausal hormone therapy. Link:
aafp.org
Recent publications in the medical literature and the popular press misattribute dozens of symptoms to menopause, stressing the health benefits of menopausal hormone therapy while underplaying its...
0
1
2
"What you see over time is that industry’s priorities become agency priorities" says Dr. Reshma Ramachandran in NYT's "Inside the Collapse of the F.D.A.".
nytimes.com
How the new health secretary, Robert F. Kennedy Jr., is dismantling the agency.
0
0
0